- Book
- January 2021
Global
- Report
- November 2021
- 527 Pages
Global
From €3534EUR$4,000USD£3,096GBP
- Report
- November 2021
- 545 Pages
Global
From €3534EUR$4,000USD£3,096GBP
- Report
- November 2021
- 802 Pages
Global
From €4417EUR$5,000USD£3,870GBP
- Report
- November 2021
- 1184 Pages
Global
From €5300EUR$6,000USD£4,644GBP
- Report
- November 2021
- 233 Pages
Global
From €2208EUR$2,500USD£1,935GBP
- Report
- November 2021
- 1165 Pages
Global
From €5300EUR$6,000USD£4,644GBP

The RNA market is a subset of the genomics market that focuses on the study of ribonucleic acid (RNA). RNA is a molecule that plays a key role in the regulation of gene expression and is involved in many cellular processes. It is used in a variety of applications, including diagnostics, therapeutics, and research.
The RNA market is expected to grow at a steady rate due to the increasing demand for RNA-based products and services. This growth is driven by advances in technology, such as next-generation sequencing, which has enabled the development of more accurate and cost-effective RNA-based products. Additionally, the increasing prevalence of chronic diseases and the need for personalized medicine are expected to drive the growth of the RNA market.
Companies in the RNA market include Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, Bio-Rad Laboratories, and F. Hoffmann-La Roche. Show Less Read more